The Role of Ion-Doped Hydroxyapatite in Drug Delivery, Tissue Engineering, Wound Healing, Implants, and Imaging

The ion doping of hydroxyapatite (HA) has gained appeal as a chemical method of improving and adding new characteristics to materials used in biomedical engineering. Dimension, morphology, porosity, surface charge, topology, composition, and other material characteristics make doped HA more suitable for specific biomedical applications. The main aim of this review study was to highlight the role of iHA (iHA) in developing drug delivery systems, tissue engineering, implant coating, wound healing, and multimodal imaging. To the best of our knowledge, depending on the dopant, iHA can have inherent distinct mechanical, physicochemical, and biological properties that make it eligible for biomedical application. More importantly, some ions make iHA a potent antibacterial agent and drug carrier for wound healing (e.g., silver, copper, zinc), have tissue engineering capabilities, improved proangiogenic and osteoconductive properties (e.g., strontium, cobalt, nickel), drug loading capacity (e.g., magnesium, ferric, strontium), metallic implant coating properties (e.g., manganese, silver, copper), and multimodal imaging potential (e.g., terbium, ytterbium, cerium). The concentration of ions and the number of dopants played a vital role in developing new approaches based on iHA. In conclusion, iHA, compared to HA, could show better improvements in biomedical applications.